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Obesity levels, especially in children, have dramatically increased over the last few
decades. Recently, several studies highlighted the involvement of gut microbiota in the
pathophysiology of obesity. We investigated the composition of gut microbiota in obese
adolescents and adults compared to age-matched normal weight (NW) volunteers
in order to assemble age- and obesity-related microbiota profiles. The composition
of gut microbiota was analyzed by 16S rRNA-based metagenomics. Ecological
representations of microbial communities were computed, and univariate, multivariate,
and correlation analyses performed on bacterial profiles. The prediction of metagenome
functional content from 16S rRNA gene surveys was carried out. Ecological analyses
revealed a dissimilarity among the subgroups, and resultant microbiota profiles differed
between obese adolescents and adults. Using statistical analyses, we assigned, as
microbial markers, Faecalibacterium prausnitzii and Actinomyces to the microbiota
of obese adolescents, and Parabacteroides, Rikenellaceae, Bacteroides caccae,
Barnesiellaceae, and Oscillospira to the microbiota of NW adolescents. The predicted
metabolic profiles resulted different in adolescent groups. Particularly, biosynthesis
of primary bile acid and steroid acids, metabolism of fructose, mannose, galactose,
butanoate, and pentose phosphate and glycolysis/gluconeogenesis were for the
majority associated to obese, while biosynthesis and metabolism of glycan, biosynthesis
of secondary bile acid, metabolism of steroid hormone and lipoic acid were associated
to NW adolescents. Our study revealed unique features of gut microbiota in terms
of ecological patterns, microbial composition and metabolism in obese patients. The
assignment of novel obesity bacterial markers may open avenues for the development
of patient-tailored treatments dependent on age-related microbiota profiles.
Keywords: gut microbiota, obesity, bacterial markers, metabolic pathways, dysbiosis
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INTRODUCTION
There has been a dramatic increase in the prevalence of obesity
over the last few decades, with the total number of overweight and
obese individuals increasing globally from 857 million in 1980 to
2.1 billion in 2013 (Nicolucci and Reimer, 2016). Of particular
concern is the 47.1% increase in the prevalence of childhood
obesity between 1980 and 2013 (Nicolucci and Reimer, 2016).
In the United States, there has been a dramatic increase in
obesity and extreme obesity from the period 1988–1994 to the
period 2013–2014: in particular, obese adolescents increased from
10.5 to 20.6%, and extremely obese adolescents from 2.6 to 9.1%
(Ogden et al., 2016).
According to a report by the Organization for Economic
Co-operation and Development, in 2014 in Italy, approximately 1
out of 10 adults was obese, while 40% were overweight (including
obesity). With regard to children, 36% of boys and 34% of
girls were overweight or obese (Organization for Economic Co-
operation and Development, 2014).
Childhood obesity tends to persist into adulthood. Therefore,
obesity in children implies both immediate and imminent
co-morbidity risks, many of which are similar to those observed
in adults (e.g., asthma and cognitive impairment in childhood,
diabetes, heart disease, several cancers, respiratory diseases,
mental health, and reproductive disorders later in life) (Adair
et al., 2016). Obesity in childhood is a public health challenge
that will require low cost, non-invasive and targeted interventions
(Keating et al., 2011; Kalra et al., 2012; Ogden et al., 2014). To
prevent long-term consequences of obesity on health, bariatric
surgery has also been advocated in adolescents (Leslie et al.,
2009). However, less than 1% of all weight loss procedures are
currently performed in adolescents, though this percentage may
increase with time (Burguera et al., 2007).
Studies on obese humans and animals have provided some
of the most persuasive indications of the intricate and mutually
beneficial interactions between bacteria and humans (Cani and
Delzenne, 2009; Ridaura et al., 2013). Gut bacteria is involved
in the regulation of host energy metabolism and body mass
(Clarke et al., 2012). Specifically, the intestinal microbiota
was shown to be a key factor in the degradation of non-
digestible nutriments, such as plant polysaccharides and fibers
(Chiu et al., 2014). Moreover, the gut microbiota influences
host physiology and contributes to nutrition and metabolic
health (Koh et al., 2016). Indeed, modulation of the gut
microbiota by consumption of fiber, antibiotic treatment or fecal
transplantation can have positive effects on inflammation and
insulin sensitivity (Robertson et al., 2005; Cani et al., 2008). An
altered gut microbiota has been observed in obesity and T2D
(Larsen et al., 2010; Karlsson et al., 2013; Le Chatelier et al.,
2013), and in particular decreased species and gene richness have
been linked to adiposity, dyslipidemia, and insulin resistance
(Cotillard et al., 2013).
Genome sequencing experiment of several gut organisms
evidenced the presence of enzymatic capacities intrinsic to gut
bacteria lacking in the human genome. This is the evidence that
microorganisms make it possible to digest diet components that
would be otherwise inaccessible to the host (Xu et al., 2003).
A primary end point of this prospective study was to
investigate the composition of the gut microbiota in obese
adolescents versus adults, and in normal weight (NW) health
teenagers and adults. A secondary end point was to identify
specific microorganisms and bacterial metabolic pathways
that correlated with obesity, focusing on possible age-related
biomarkers.
MATERIALS AND METHODS
Patient and Control Recruitment
Obese patients were prospectively enrolled at the obesity clinic.
Twenty adult patients with an indication for bariatric surgery
were screened following the guidelines of the Italian Society for
Obesity Surgery (Sicob1). Twenty-five adolescent patients were
enrolled for bariatric surgery according to the guidelines of
ESPGHAN (Nobili et al., 2015).
To obtain an age-matched control-case study, 12 NW
healthy adolescents (CTRL_ado) and 12 NW healthy adults
(CTRL_adult) were enrolled as volunteers during the same period
at the OPBG Metagenomics Human Microbiome Unit and
at the Clinical Medicine Department of Umberto I Hospital,
respectively. Anamnestic and clinical data for obese patients and
CTRLs are reported in Table 1. From each subjects/patients a
single stool sample was collected and stored at −80◦C until the
end of collection.
Co-morbidity assessment, and psychological and nutritional
counseling were performed in an outpatient setting. Inclusion
criteria were: Caucasian race; age 13–19 years for obese
adolescents (ob_ado) and 20–65 years for obese adults
(ob_adult); body mass index (BMI) between 30 and 60 kg/m2;
eligibility for bariatric surgery (Sleeve Gastrectomy). Exclusion
criteria were: histological positivity to Helicobacter pylori; intake
of corticosteroids, antibiotics, or pre-probiotics in the previous
2 months; intake of vitamin E or fish oil in the previous 2 months;
chronic gastrointestinal diseases or syndromes (e.g., IBD and
IBS); previous bariatric surgery (intragastric balloon excluded).
The criteria for healthy CTRL enrolment were: BMI between
18.5 and 24.9 kg/m2 for adults (World Health Organization
[WHO], 2000) and BMI between the 5th and the 85th percentile
of BMI-for-age, for adolescents (Ogden et al., 2002), absence
of chronic diseases; absence of gastrointestinal infections in the
previous 2 months, no antibiotic and pre-probiotic intake in the
previous 2 months, omnivorous diet.
This study was carried out in accordance with the
recommendations of the OPBG Ethics Committee (Protocol
No. 768.12) for adolescent patients and by Umberto I hospital
Ethics Committee (Protocol No. 1003/13) for adult patients. All
subjects gave written informed consent in accordance with the
Declaration of Helsinki.
Arterial Hypertension was defined according to the modified
NCEP ATP-III criteria. Blood pressure (mmHg) was registered
after 5 min of rest using an electronic auscultatory blood pressure
recorder with an appropriately sized cuff, and with the patient
1www.sicob.org
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TABLE 1 | Anamnestic and clinical data of patients and CTRLs.
ob_ado ob_adult CTRL_ado CTRL_adult
N. of subjects 25 20 12 12
Gender (female/male) 14/11 14/6 8/4 8/4
Agea (mean ± SD) 16.16 ± 2.08 40.65 ± 11.65 16.92 ± 1.08 33.75 ± 10.59
BMIb (mean ± SD) 44.82 ± 6.09 41.02 ± 7.10 20.69 ± 0.88 21.02 ± 1.51
Intragastric balloon positioning 9 – – –
Impaired glucose metabolismc 6 IGT 1 DMT2d/4 IGT – –
Blood hypertensione – 10 yes – –
aAge in years; bBMI in kg/m2; c impaired glucose metabolism: no, yes, impaired glucose tolerance (IGT); dDMT2: diabetes mellitus type 2; eblood hypertension: no, yes.
sitting in the upright position. Three measurements were taken,
and the average of the second and third measurements was
recorded and used in the analysis. Patients were considered as
affected by hypertension when values were over 135/80 mmHg.
Impaired glucose metabolism was defined according to
the American Diabetes Association (ADA) criteria (American
Diabetes Association, 2009). Patients underwent an oral glucose
tolerance test (OGTT) with glycemia measurement at baseline
and 30, 60, 90, and 120 min after the ingestion of 75 g of glucose.
Patients were defined as Normal Glucose Tolerant (NGT) with
glycemia values under 140 mg/dl at 120 min of OGTT; impaired
glucose tolerant (IGT) with glycemia values between 140 and
200 mg/dl at 120 min of OGTT; type 2 diabetes patients (DMT2)
with glycemia values over 200 mg/dl.
Genomic DNA Extraction,
Pyrosequencing, and Quantitative
Analysis of the Microbiome Composition
Genomic DNA was isolated from the entire set of 69 stool
samples, using the QIAamp DNA Stool Mini Kit (Qiagen,
Germany). DNA quantity and quality was assessed by
NanoDropTM 2000/2000c spectrophotometer (Thermo
Scientific, Wilmington, MA, United States). For the 16S
rRNA-based metagenomics, the V1–V3 regions (520 bp) of the
16S rRNA gene were amplified to obtain bacterial library using
universal bacterial primers (FW 5′-GAGTTTGATCNTGGCTCA
G-3′, RV 5′-GTNTTACNGCGGCKGCTG-3′). Primers were
barcoded by eight unique nucleotide sequences (Roche 454
Life Sciences, Branford, CT, United States). To guarantee
high specificity, sensitivity and accuracy of PCR reaction, a
Hi-Fi PCR Taq polymerase (FastStartTM High Fidelity PCR
System, dNTPack, Roche Diagnostics, Mannheim, Germany)
was employed. To limit the per base PCR error rates and
chimeric sequences 40 cycles of PCR, 5 min of extension
time, a low template concentrations (1 ng) conditions were
applied (Lahr and Katz, 2009). Each samples was submitted to
pyrosequencing reaction on a 454-Junior Genome Sequencer
(Roche 454 Life Sciences, Branford, CT, United States), according
to manufacturer’s instructions.
The 454 Amplicon signal processing was used as first result
filtering, hence by QIIME 1.8.0 software the sequences were
analyzed (Caporaso et al., 2010). After demultiplexing, reads with
an average quality score lower than 25, shorter than 300 bp and
with an ambiguous base calling were excluded from the analysis.
Sequences that passed the quality filter were denoised (Reeder
and Knight, 2010) and singletons were excluded. The denoised
sequences were chimera-checked by identify_chimeric_seqs.py
using either Blast_fragments and ChimeraSlayer2 approaches.
The operational taxonomic units (OTUs) defined by a 97% of
similarity were picked and the representative sequences were
submitted to PyNAST for the sequence alignment (Caporaso
et al., 2010), and to UCLUST for sequence clustering (Edgar,
2010). The database for OTUs matching was greengenes (v 13.8).
After rarefying, the α- and β-diversity and the ANOSIM tests
were carried out by QIIME software, using alpha_rarefaction.py,
beta_diversity_through_plots.py, compare_categories.py scripts;
the group_significance.py script was used to perform OTUs
Kruskal–Wallis test (Navas-Molina et al., 2013).
Statistical Analysis
Operational taxonomic units present in less than 25% of the
samples were removed prior to applying statistical analysis. At
the end of the filtering process, the taxa taken into consideration
for subsequent statistical analyses were reduced to 47/222 OTUs.
Statistical tests [Shapiro–Wilk test, ANOVA, least significant
difference (LSD) test, Mann–Whitney U-test, receiver operating
characteristic (ROC), discriminant analysis (DA), principal
component analysis (PCA), Wilks’ Lambda test, Spearman’s
correlations] were performed by IBM SPSS statistic software
version 21.
To predict metagenome functional content from 16S rRNA
gene surveys, Picrust v 1.1.0 tool have been applied (Langille
et al., 2013) and to obtain the KEGG (Kyoto Encyclopedia
of Genes and Genomes) pathways3 we analyzed the function
prediction by HUMAnN2 v0.99 program (Abubucker et al.,
2012). Furthermore, to find KEGGs biomarkers associated with
adolescent obese and CTRL conditions, a linear discriminant
effect size (LeFse) analysis have been performed (α value = 0.05,
logarithmic LDA score threshold = 2.0) (Segata et al., 2011).
MG Data Open Access Repository
Sequencing reads and the associated metadata are available at
NCBI: Bioprojects: PRJNA356507, gut metagenomic profile from
2http://qiime.org/scripts/identify_chimeric_seqs.html
3http://huttenhower.sph.harvard.edu/humann2
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obese patients; PRJNA280490, gut metagenomic profile from
healthy subjects4.
RESULTS
Microbiota Profiles in Obese Patients
and in Healthy Controls
A total of 139,783.00 sequencing reads were obtained from 69
fecal samples, with a mean value of 2,025.84 sequences per
sample. We identified an overall of 222 OTUs, grouped in 14
phylum and 79 families.
To assess the overall differences of microbial community
structures in patients and CTRLs, we measured ecological
parameters based on alpha-diversity (ChaoI, Shannon indexes).
4http://www.ncbi.nlm.nih.gov/bioproject/?term=
The highest mean value of the ChaoI index was obtained for
the CTRL_ado group (242.28), followed by CTRL_adult (180.23),
ob_ado (166.03), and ob_adult (149.28) groups (Supplementary
Figure S1A). The mean Shannon index values are similar amongst
the four groups (Supplementary Figure S1B).
To determine the differences between microbial community
structures in obese patients and CTRLs, we calculated β-diversity.
Our results showed that, by weighted UniFrac analysis, the
first coordinate (PC1) explained the 30.23% of the intersample
variance (p = 0.01; Figure 1A), while the unweighted UniFrac
analysis explained the 11.05% in obese versus CTRL group
(p = 0.01; Figure 1C). Stratifying samples by age, we found that
the two adolescent groups (ob_ado and CTRL_ado) formed more
defined and separated clusters than the adult groups (p = 0.01;
Figures 1B,D).
Grouping OTUs at phylum level, we took into consideration
the relative abundances of the five major phyla (e.g.,
Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria,
FIGURE 1 | Principal coordinates analysis (PCoA) plot of obese and CTRL groups (A–C), and of CTRL_ado, CTRL_adult, ob_ado, and ob_adult groups (B–D). The
plots show the first two principal coordinates (axes) for PCoA using a weighted (A,B) and unweighted (C,D) UniFrac algorithm.
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and Verrucomicrobia). Applying the Kruskal–Wallis test
on the relative abundances of phyla for the four groups, we
observed statistically significant differences in the distributions
of Actinobacteria, Bacteroidetes, and Firmicutes (p < 0.05).
However, a false discovery rate (FDR) correction of p-values
defined Actinobacteria as the only significant taxon differentially
describing the four groups (Figure 2A and Supplementary
Table S1).
Particularly, the distribution of Actinobacteria
and Bacteroidetes were statistically significant for the
ob_ado/ob_adult couple, with Actinobacteria levels being
higher in the ob_ado group, and Bacteroidetes levels being
uppermost in the ob_adult group. Actinobacteria, Bacteroidetes,
and Firmicutes were statistically significant for adolescent obese
versus CTRL (Supplementary Table S2).
At OTU level the Kruskal–Wallis test revealed the following
statistically significant comparisons: Actinomyces, Adlercreutzia,
Bacteroides caccae, Barnesiellaceae, Clostridiaceae, Collinsella
aerofaciens, Faecalibacterium prausnitzii, Gemellaceae,
Lachnospiraceae, Oscillospira, Propionibacterium acnes,
Streptococcus, and Veillonella parvula ([p]FDR < 0.05; Figure 2B
and Supplementary Table S3).
By the Mann–Whitney U-test, applied to the above mentioned
13 OTUs, we identified that Actinomyces. Adlercreutzia and
C. aerofaciens and F. prausnitzii were higher in ob_ado
respect to ob_adult (p < 0.05; Table 2). Interestingly, a high
number of comparisons were statistically significant in the
pairwise ob_ado versus CTRL_ado, particularly Actinomyces,
Adlercreutzia, Clostridiaceae, C. aerofaciens, F. prausnitzii,
Lachnospiraceae, P. acnes, Streptococcus, and V. parvula were
FIGURE 2 | Bar chart representing Kruskal–Wallis test results on operational taxonomic units (OTUs) grouped in phyla (A) and in families/species (B) of the
CTRL_ado, CTRL_adult, ob_ado, ob_adult groups. Each column in the plot represents a group, and each color in the column represents: (A) the percentage of
relative abundance for each OTU; (B) the values of relative abundance for each OTU.
Frontiers in Microbiology | www.frontiersin.org 5 June 2018 | Volume 9 | Article 1210
fmicb-09-01210 June 2, 2018 Time: 21:3 # 6
Del Chierico et al. Gut Microbiota Age-Dependent Patterns in Obesity
TA
B
LE
2
|M
an
n–
W
hi
tn
ey
U
-t
es
to
n
O
TU
s
at
fa
m
ily
/s
pe
ci
es
le
ve
lf
or
th
e
C
TR
L_
ad
o,
C
TR
L_
ad
ul
t,
ob
_a
do
,o
b_
ad
ul
tg
ro
up
s.
M
ea
n
o
f
re
la
ti
ve
ab
un
d
an
ce
s
O
T
U
s
o
b
_a
d
o
o
b
_a
d
ul
t
o
b
_a
d
o
C
T
R
L_
ad
o
o
b
_a
d
o
C
T
R
L_
ad
ul
t
o
b
_a
d
ul
t
C
T
R
L_
ad
o
o
b
_a
d
ul
t
C
T
R
L_
ad
ul
t
C
T
R
L_
ad
o
C
T
R
L_
ad
ul
t
A
ct
in
om
yc
es
a,
b,
c
0.
00
2
0.
00
0
0.
00
2
0.
00
1
0.
00
2
0.
00
0
0.
00
0
0.
00
1
0.
00
0
0.
00
0
0.
00
1
0.
00
0
A
dl
er
cr
eu
tz
ia
a,
b
0.
00
3
0.
00
0
0.
00
3
0.
00
0
0.
00
3
0.
00
1
0.
00
0
0.
00
0
0.
00
0
0.
00
1
0.
00
0
0.
00
1
B
ac
te
ro
id
es
ca
cc
ae
b,
d,
f
0.
00
1
0.
00
0
0.
00
1
0.
02
0
0.
00
1
0.
00
0
0.
00
0
0.
02
0
0.
00
0
0.
00
0
0.
02
0
0.
00
0
B
ar
ne
si
el
la
ce
ae
b,
d,
f
0.
00
4
0.
00
4
0.
00
4
0.
02
7
0.
00
4
0.
00
6
0.
00
4
0.
02
7
0.
00
4
0.
00
6
0.
02
7
0.
00
6
C
lo
st
rid
ia
ce
ae
b,
c,
d
0.
07
9
0.
02
1
0.
07
9
0.
00
7
0.
07
9
0.
02
1
0.
02
1
0.
00
7
0.
02
1
0.
02
1
0.
00
7
0.
02
1
C
ol
lin
se
lla
ae
ro
fa
ci
en
sa
,b
,c
0.
00
9
0.
00
1
0.
00
9
0.
00
1
0.
00
9
0.
00
1
0.
00
1
0.
00
1
0.
00
1
0.
00
1
0.
00
1
0.
00
1
Fa
ec
al
ib
ac
te
riu
m
pr
au
sn
itz
iia
,b
,c
,d
,e
0.
11
1
0.
02
7
0.
11
1
0.
00
7
0.
11
1
0.
01
7
0.
02
7
0.
00
7
0.
02
7
0.
01
7
0.
00
7
0.
01
7
G
em
el
la
ce
ae
0.
00
3
0.
00
0
0.
00
3
0.
00
0
0.
00
3
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
0.
00
0
La
ch
no
sp
ira
ce
ae
b,
d,
f
0.
07
9
0.
06
1
0.
07
9
0.
02
0
0.
07
9
0.
07
9
0.
06
1
0.
02
0
0.
06
1
0.
07
9
0.
02
0
0.
07
9
O
sc
illo
sp
ira
b,
c,
d,
f
0.
00
8
0.
02
1
0.
00
8
0.
04
3
0.
00
8
0.
01
9
0.
02
1
0.
04
3
0.
02
1
0.
01
9
0.
04
3
0.
01
9
P
ro
pi
on
ib
ac
te
riu
m
ac
ne
sb
,c
,d
,e
0.
00
1
0.
00
1
0.
00
1
0.
00
0
0.
00
1
0.
00
0
0.
00
1
0.
00
0
0.
00
1
0.
00
0
0.
00
0
0.
00
0
S
tr
ep
to
co
cc
us
b,
d,
f
0.
04
0
0.
03
1
0.
04
0
0.
00
4
0.
04
0
0.
02
0
0.
03
1
0.
00
4
0.
03
1
0.
02
0
0.
00
4
0.
02
0
Ve
illo
ne
lla
pa
rv
ul
ab
0.
00
2
0.
00
5
0.
00
2
0.
00
0
0.
00
2
0.
00
0
0.
00
5
0.
00
0
0.
00
5
0.
00
0
0.
00
0
0.
00
0
Fo
r
ea
ch
gr
ou
p
th
e
m
ea
n
of
re
la
tiv
e
ab
un
da
nc
es
is
re
po
rt
ed
in
co
lu
m
ns
.a
S
ig
ni
fic
at
iv
e
p-
va
lu
e
fo
r
ob
_a
do
ve
rs
us
ob
_a
du
lt;
b
si
gn
ifi
ca
tiv
e
p-
va
lu
e
fo
r
ob
_a
do
ve
rs
us
C
TR
L_
ad
o;
c
si
gn
ifi
ca
tiv
e
p-
va
lu
e
fo
r
ob
_a
do
ve
rs
us
C
TR
L_
ad
ul
t;
d
si
gn
ifi
ca
tiv
e
p-
va
lu
e
fo
r
ob
_a
du
lt
ve
rs
us
C
TR
L_
ad
ul
t;
e
si
gn
ifi
ca
tiv
e
p-
va
lu
e
fo
r
ob
_a
du
lt
ve
rs
us
C
TR
L_
ad
ul
t;
f s
ig
ni
fic
at
iv
e
p-
va
lu
e
fo
r
C
TR
L_
ad
o
ve
rs
us
C
TR
L_
ad
ul
t.
higher in the ob_ado group, while B. caccae, Barnesiellaceae,
and Oscillospira were higher in CTRL_ado group (p < 0.05)
(Supplementary Table S4). Finally, F. prausnitzii and P. acnes
were higher in ob_adult respect to CTRL_adult.
Detecting Microbial Biomarkers in Obese
Patients and Healthy Controls
To define a model based on the capability of OTUs to
discriminate the four groups of study participants, we performed
a discriminant analysis (DA) based on univariate ANOVAs,
Fisher’s coefficient and leave-one-out classification.
A DA showed that 98.6% of the original grouped cases
were correctly classified, and the canonical discriminant plot
revealed a clear separation between obese and CTRL groups
(Figure 3 and Supplementary Table S5). In particular, the
Figure Shows a clear separation between the samples belonging
to the four groups, with most of the samples being close to the
centroid of the group of belonging, although a lower separation
was observed between obese groups (ob_ado and ob_adult)
(Figure 3). However, applying a cross-validation (CV) test, we
found that only 34.8% of cases were correctly classified, revealing
a low capability of the entire OTUs set to discriminate the
four groups (Supplementary Table S5). For this reason, using a
p < 0.05 filter (from a Wilks’ Lambda test) we selected only 12
OTUs (Supplementary Figure S2 and Supplementary Table S6)
and tested their discriminatory power in correctly classifying
groups by applying the average area under the ROC.
The area under the ROC curve (AUROC) for the ob_ado
group was 0.75 for F. prausnitzii, and 0.735 for Actinomyces; for
the CTRL_ado group, it was 0.706 for Parabacteroides, 0.731 for
Rikenellaceae, 0.781 for B. caccae, 0.848 for Barnesiellaceae, and
0.725 for Oscillospira (Supplementary Table S7). For ob_adult
and CTRL_adult groups, AUROC values were <0.7 and then
considered not accurate in discriminating study groups (Swets,
1988).
These results indicated that F. prausnitzii and Actinomyces
were accurate in discriminating the ob_ado group, and
Parabacteroides, Rikenellaceae, B. caccae, Barnesiellaceae, and
Oscillospira allowed us to discriminate the CTRL_ado group
(Figure 4). However, none of the OTUs was able to discriminate
adult groups. These results were confirmed and validate by DA
and CV analyses (Supplementary Table S8).
Correlations Between
Clinical/Anthropometric Characteristics
and Bacterial Abundance
To evaluate correlations amongst bacteria, and clinical and
anthropometric characteristics (e.g., age, gender, BMI, the
presence of diabetes and hypertension), we selected Spearman’s
rho cut-off values, also taking into account r > 0.4, r < −0.4
(p < 0.05).
For ob_ado patients, Spearman’s correlation analysis revealed
that only Erysipelotrichaceae negatively correlated with the BMI.
Anaerostipes negatively correlated with age, while P. distasonis
positively correlated with age. Conversely, diabetes was positively
correlated with the presence of Bacteroides, Parabacteroides,
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FIGURE 3 | Canonical discriminant plot. Scatter plot of canonical discriminant analysis (DA) based on univariate ANOVA and Fisher’s coefficient applied to all OTUs
of samples belonging to CTRL_ado, CTRL_adult, ob_ado, and ob_adult groups.
P. copri and P. distasonis, while no OTU correlated with
hypertension and gender features (Supplementary Figure S3 and
Supplementary Table S9).
For the ob_adult group, Coprococcus positively correlated
with the BMI, while Bacteroides fragilis, Dehalobacterium,
Lachnospira, and Enterobacteriaceae negatively correlated
with the BMI. Blautia and Lachnospiraceae negatively
correlated with gender. Moreover, diabetes was positively
correlated with the presence of Bacteroidaceae, P. distasonis,
Lachnospiraceae and Blautia, but was negatively correlated with
Prevotella, Lachnospira and Enterobacteriaceae. Hypertension
correlated with Sutterella, Butyricimonas, and Paraprevotella.
No OTU correlated with age (Supplementary Figure S3 and
Supplementary Table S9). Correlation analysis in the CTRL_ado
group revealed a positive correlation between age and the
BMI, and a negative correlation between age and F. prausnitzii.
Surprisingly, gender positively correlated with the presence
of P. acnes, Erysipelotrichaceae and Enterobacteriaceae.
Moreover, F. prausnitzii was negatively correlated with the BMI
(Supplementary Figure S3 and Supplementary Table S10).
In the CTRL_adult group, no correlation between OTUs and
age was found, while A. muciniphila negatively correlated with
BMI. Furthermore, gender negatively correlated with Blautia,
and positively with Clostridium and Sutterella (Supplementary
Figure S3 and Supplementary Table S10).
Metabolic Pathway Predictions
A total of 20 KEGG pathways were generated using the
composition of the gut microbiota based on PICRUSt in
adolescent versus adult obese, of which lipopolysaccharide, folate,
vitamin B6, inositol phosphate, flavonoid biosynthesis pathways
were higher in adolescent, while arginine and proline, amino
and nucleotide sugar, starch and sucrose galactose metabolism
pathways were higher in adults (Supplementary Figure S4).
Moreover, 60 differential metabolic patterns differentially
expressed resulted in the ob_ado versus CTRL_ado comparison.
Thirty-four KEGG pathways were significantly upregulated in
the ob_ado group while 26 were significantly upregulated in
CTRL_ado group. Among them, primary bile acid biosynthesis,
steroid acids biosynthesis, fructose and mannose metabolism,
glycolysis/gluconeogenesis, galactose metabolism, butanoate
metabolism, and pentose phosphate metabolism were for
the majority associated to obese, while glycan biosynthesis
and metabolism, secondary bile acid biosynthesis, steroid
hormone biosynthesis, and lipoic acid metabolism were
associated to NW adolescents (Supplementary Figure S5). In the
comparison between adults we obtained 10 pathways associated
obese and 9 associated to NW condition. Among pathways
associated to adult obese were taurine and hypotaurine,
beta-alanine, propanoate, tryptophan metabolism, while
nitrogen, amino and nucleotide sugars, alanine, aspartate, and
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FIGURE 4 | Receiver operating characteristic (ROC) curve plots. The areas under the ROC curves (AUROC) represent the specificity and sensitivity of the seven
selected OTUs (AUROC > 0.7) able to discriminate ob_ado (A) and CTRL_ado (B) groups.
glutamate metabolism were associated to NW (Supplementary
Figure S6).
DISCUSSION
In this study, we characterized gut microbiota profiles in obese
adolescents and adults, and compared these to NW healthy age-
matched study participants.
The gut microbiota may be considered a microbial metabolic
organ because of its influence on the regulation of energy uptake
from the diet, its involvement in host metabolism, and the release
of gut hormones (Hullar and Lampe, 2012). Several studies on
the gut microbiome have shown obese individuals harbor less
diverse bacterial communities than lean individuals (Turnbaugh
et al., 2009; Pihl et al., 2016). In particular, Le Chatelier et al.
(2013) showed that individuals with low bacterial richness
presented with a marked overall adiposity, insulin resistance and
dyslipidemia compared with individuals showing high bacterial
richness.
Studies based on both animal and human models have
described an altered OTU composition in fecal microbiota related
to obesity (Turnbaugh et al., 2006; Zhang et al., 2009; Clarke
et al., 2012; Chiu et al., 2014). Moreover, these studies reported
conflicting results on the microbiota’s composition, leading to
confusing conclusions on microorganisms’ roles, both in terms of
pathogenicity and protective bacteria, the latter being helpful for
the identification of tailored probiotics. The large inter-individual
variation in microbiota composition related to obesity is probably
due to the employment of different research methodologies and
the involvement of participants with different backgrounds (food
habits and ethnicity) (Aguirre and Venema, 2015).
It has been found that gut microbiota in humans and animal
models of obesity is reduced in abundance of Bacteroidetes
with a proportional increase in Firmicutes phylum, however,
these results have been contradicted by other studies reporting
divergent ratios between these two phyla (Duncan et al., 2008;
Abdallah Ismail et al., 2011; Harris et al., 2012).
Our study focused not only on differences in the composition
of gut microbiota of obese patients compared to CTRLs, but
also on changes between young and adult study participants in
order to verify an age-related association between microbes and
obesity.
The microbiota profile in obese adolescents resulted
differentially composed respect to obese adults, leading to
suppose a synergic role of age and obesity in microbiota
composition. However, the main differences in microbiota
composition were evidenced comparing adolescent obese and
NW. In fact, the OTU-based model assigned the microbial
markers F. prausnitzii and Actinomyces to the ob_ado group, and
Parabacteroides, Rikenellaceae, B. caccae, Barnesiellaceae, and
Oscillospira to the CTRL_ado group.
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Faecalibacterium prausnitzii is one of the most common
species in the gastrointestinal tract of adults consuming a
Western diet (Scott et al., 2013) and its presence has been
associated with lower success in weight loss diets (Le Chatelier
et al., 2013). Furthermore, F. prausnitzii has a key role in
host metabolism as it allows the fermentation of unabsorbed
carbohydrate. The presence of F. prausnitzii in the gut of
obese adolescents may lead to increased energy recovery from
unabsorbed carbohydrate that would not otherwise contribute to
dietary energy intake (Balamurugan et al., 2010).
In our study, Actinomyces was also found to be related to
the gut microbiota of obese adolescents. Actinomyces species
are part of the normal, resident microbiota of the mouth. They
contributed to different plaque related diseases (Moore and
Moore, 1994), and correlated with a glucose diet (Matee et al.,
1993). Moreover, in two case reports, Actinomyces were found
responsible for gastric actinomycosis as a complication after
gastric bypass for morbid obesity (Fernández-Aceñero et al.,
2004; Baierlein et al., 2007).
Amongst the OTUs that correlated with the gut microbiota
of NW healthy participants, we found Parabacteroides, and
B. caccae, both belonging to the Bacteroidetes phylum.
P. distasonis is prominently found in the gut of healthy
individuals (Xu et al., 2007); and studies in humans and in
mouse models demonstrated a positive correlation between
Bacteroidetes and weight loss (Cani et al., 2008; Nadal et al.,
2009).
Regarding the association of Barnesiellaceae with the NW
group, Chiu et al. (2014) reported higher levels of Barnesiella
(belonging to Barnesiellaceae family) in control individuals
compared to obese patients.
Finally, in our previous study on non-alcoholic fatty liver
patients, we reported a higher abundance of Oscillospira,
Rikenellaceae, Parabacteroides, B. fragilis, in CTRLs compared
to patients, consistently with present data (Del Chierico et al.,
2016).
Changes in functional capacity of gut microbiota indicated
by KEGG pathways were different between adolescent and adult
obese. In particular, adolescent obese microbiota was enriched
by lipopolysaccharide metabolism, that have been recognized
to initiate the inflammation-related processes associated with
the onset of obesity and insulin resistance (Boulangé et al.,
2016). Vitamin B6 is required for the synthesis of fat from
carbohydrate and protein (Zhou and Zhou, 2014). However,
inositol phosphate, folate, flavonoid biosynthesis pathways seems
to have a role against the obesity. In particular, inositol plays
a role in glucose metabolism control, reducing BMI (Saleem
and Rizvi, 2017); folate treatment improved insulin resistance
and endothelial dysfunction in patients with metabolic syndrome
(Pinhas-Hamiel et al., 2006); flavonoids seem to have potential
benefit role against obesity (Kawser Hossain et al., 2016).
In adults, obese microbiome compared with NW
resulted enriched in pathways involved in the initial steps
in breaking down indigestible dietary polysaccharides,
including starch/sucrose metabolism, galactose metabolism
(Turnbaugh et al., 2006), but also glutamate and carbohydrate
metabolism.
As already evidenced in the microbiota profile description,
the main differences in KEEG pathway profiles were obtained
comparing adolescents obese and NW. The NW microbiota of
adolescents is significantly enriched in glycan biosynthesis and
metabolism pathways. Mostly of glycans arise from rich fiber
FIGURE 5 | Gut microbiota model in obese and normal weight (NW) controls. Gut microbiota ecological richness (ChaoI index) results are lower in obese patients
with respect to NW study participants. The microbiota profile (OTU distribution) is completely different in the four groups. By applying statistical analyses, it has been
possible to generate a model able to associate microbial and metabolic markers with obese and NW adolescents.
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diet and host mucosal secretions. Microbes ferments indigestible
glycans producing short chain fatty acids (SCFAs), which are
nutrients for colonocytes and enterocytes (Koropatkin et al.,
2012).
Greater primary bile acid biosynthesis was associated to
obese adolescents, while secondary bile acid biosynthesis was
associated to NW subjects. Primary bile acids (i.e., cholate and
chenodeoxycholate), are deconjugated by several gram-positive
bacterial species, such as Lactobacilli (Begley et al., 2006). After
deconjugation, additional microbial modifications give rise to
the formation of secondary bile acids (Jones et al., 2008),
which is only carried out by a minor population of gram-
positive anaerobic Clostridium species (Kitahara et al., 2004).
Interestingly, bile acids, particularly secondary ones, influence
energy expenditure and glucose homeostasis via their effects on
gluconeogenesis, insulin secretion and insulin sensitivity (Vrieze
et al., 2014).
Furthermore, steroid hormone biosynthesis and lipoic acid
metabolism pathways were associated to NW subjects. Regulation
of some key proteins in adipose tissues by sex steroid hormones
may also be a mechanism for the treatment and/or prevention
of obesity (Mayes and Watson, 2004). In addition, chronic
administration of lipoic acid improves glucose tolerance and
skeletal muscle glucose transport in the obese rat (Saengsirisuwan
et al., 2004).
Notably, the obese adolescent microbiome is significantly
enriched for KEGG pathways involved in the fructose and
mannose metabolism, glycolysis/gluconeogenesis, galactose
metabolism, butanoate metabolism, and pentose phosphate
metabolism. Also in a diet-induced obesity study, the
high-fat/high-sugar Western diet was associated the
phosphotransferase system, fructose and mannose metabolism,
and glycolysis/gluconeogenesis pathways, due to a blooming of
Firmicutes with reduction on Bacteroidetes (Turnbaugh et al.,
2008). Furthermore, the study of Kim and Bae (2016) highlighted
that the mucosal and luminal viromes of obese mice were
significantly enriched with temperate phages associated with
the Bacilli, Negativicutes and Bacteroidia classes. Particularly,
the temperate phages from the Bacteroidia class encoded stress
and niche-specific functions advantageous to bacterial host
adaptation showing the role of phage in the obese microbiota
shaping (Kim and Bae, 2016). Furthermore, in mice transplanted
by microbiomes from obese twins, higher expression of microbial
genes involved in the pentose phosphate pathway was highlighted
(Ridaura et al., 2013). Additionally, microbiome of obese mice
encoded many enzymes involved in breaking down indigestible
dietary polysaccharides, including KEGG pathways for galactose
metabolism and butanoate metabolism (Turnbaugh et al.,
2006).
This finding suggested that the gut microbiota from obese
subjects could influence metabolites that characterize the obese
state.
Therefore, the gut microbiota appears to function as an
ecological unit, the composition and local diversity of which
are largely determined by niche-driven processes (Jeraldo et al.,
2012). External factors, such as diet and lifestyle, but also diseases,
such as obesity, diabetes or metabolic syndromes, alter the niche
landscape by supplying novel nutrients, leading to fluctuations in
the microbiota structure.
CONCLUSION
This study revealed unique characteristics in ecological diversity,
composition, and metabolic pathways of the gut microbiota
of obese adolescents and adults compared to NW adolescents
and adults. Nevertheless, future studies are need to valid
these results in a more numerous cohort of patients. The
proposed model associates specific microbial biomarkers to
adolescent obese and to NW microbiota profiles (Figure 5).
These microbial targets represent differential markers in
microbiota profiling analyses. New clinical interventions, based
on microbiota modulation, may be developed for the prevention
and treatment of childhood-onset obesity. The markers identified
in this study may therefore be considered in the process of
developing new, specifically age-dependent probiotics targeted to
obesity.
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